AR Asset Management’s Novartis NVS Stock Holding History

AR Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64M	Hold	10,750	–	–	0.32%	59
2025 Q4	$1.48M	Hold	10,750	–	–	0.3%	62
2025 Q3	$1.38M	Hold	10,750	–	–	0.29%	64
2025 Q2	$1.3M	Hold	10,750	–	–	0.29%	65
2025 Q1	$1.2M	Hold	10,750	–	–	0.27%	66
2024 Q4	$1.05M	Hold	10,750	–	–	0.24%	68
2024 Q3	$1.24M	Hold	10,750	–	–	0.27%	66
2024 Q2	$1.14M	Hold	10,750	–	–	0.28%	65
2024 Q1	$1.04M	Hold	10,750	–	–	0.25%	67
2023 Q4	$1.08M	Hold	10,750	–	–	0.28%	64
2023 Q3	$1.09M	Hold	10,750	–	–	0.31%	63
2023 Q2	$1.08M	Hold	10,750	–	–	0.29%	62
2023 Q1	$989K	Hold	10,750	–	–	0.27%	65
2022 Q4	$975K	Hold	10,750	–	–	0.28%	62
2022 Q3	$817K	Hold	10,750	–	–	0.24%	76
2022 Q2	$909K	Hold	10,750	–	–	0.26%	74
2022 Q1	$943K	Hold	10,750	–	–	0.24%	75
2021 Q4	$940K	Hold	10,750	–	–	0.24%	73
2021 Q3	$879K	Buy	10,750 +2,700	+34%	+$243K	0.25%	73
2021 Q2	$734K	Hold	8,050	–	–	0.21%	83
2021 Q1	$688K	Hold	8,050	–	–	0.21%	82
2020 Q4	$760K	Hold	8,050	–	–	0.25%	72
2020 Q3	$700K	Sell	8,050 -100	-1%	-$8.66K	0.25%	74
2020 Q2	$712K	Hold	8,150	–	–	0.27%	78
2020 Q1	$672K	Hold	8,150	–	–	0.28%	78
2019 Q4	$772K	Hold	8,150	–	–	0.26%	76
2019 Q3	$708K	Hold	8,150	–	–	0.25%	81
2019 Q2	$744K	Sell	8,150 -945	-10%	-$80K	0.27%	76
2019 Q1	$784K	Buy	9,095 +1,283	+16%	+$103K	0.29%	73
2018 Q4	$601K	Sell	7,812 -1,283	-14%	-$99.9K	0.26%	77
2018 Q3	$702K	Hold	9,095	–	–	0.26%	77
2018 Q2	$616K	Hold	9,095	–	–	0.24%	78
2018 Q1	$659K	Hold	9,095	–	–	0.27%	75
2017 Q4	$684K	Hold	9,095	–	–	0.26%	72
2017 Q3	$700K	Hold	9,095	–	–	0.28%	76
2017 Q2	$680K	Hold	9,095	–	–	0.28%	76
2017 Q1	$605K	Hold	9,095	–	–	0.25%	77
2016 Q4	$594K	Sell	9,095 -10,212	-53%	-$662K	0.25%	76
2016 Q3	$1.37M	Hold	19,307	–	–	0.59%	43
2016 Q2	$1.43M	Hold	19,307	–	–	0.6%	46
2016 Q1	$1.25M	Buy	19,307 +11,216	+139%	+$763K	0.54%	50
2015 Q4	$624K	Sell	8,091 -5,468	-40%	-$434K	0.28%	75
2015 Q3	$1.12M	Buy	13,559 +7,867	+138%	+$700K	0.5%	56
2015 Q2	$502K	Hold	5,692	–	–	0.21%	88
2015 Q1	$503K	Hold	5,692	–	–	0.2%	84
2014 Q4	$473K	Hold	5,692	–	–	0.19%	87
2014 Q3	$480K	Hold	5,692	–	–	0.19%	86
2014 Q2	$462K	Hold	5,692	–	–	0.19%	89
2014 Q1	$434K	Buy	+5,692	New	+$415K	0.18%	91

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AR Asset Management's NVS Position: Q1 2026 in Review

AR Asset Management held its Novartis (NVS) position steady in Q1 2026 at 10,750 shares worth $1.64M. The position accounts for 0.32% of the portfolio, ranked #59.

AR Asset Management first reported a position in NVS in Q1 2014 and has held it in 49 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

AR Asset Management held 10,750 shares of Novartis worth $1.64M as of Q1 2026.
AR Asset Management left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.32% of AR Asset Management's portfolio in Q1 2026, its #59 holding.
AR Asset Management first reported a position in Novartis in Q1 2014 and has held it in 49 quarters since.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on AR Asset Management's 13F filing for Q1 2026, filed 13 May 2026.